scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)

CUSIP: 810648105

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
53,364,241
Total 13F shares
40,958,051
Share change
+2,759,037
Total reported value
$232,212,551
Put/Call ratio
21%
Price per share
$5.67
Number of holders
108
Value change
+$31,413,737
Number of buys
67
Number of sells
52

Security key

810648105

Report period

Q3 2025

Institutions

108

Top holders

10

Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
GLAZER CAPITAL, LLC
13D/G
4.6%
2,474,820
$11,829,640 $0 02 Sep 2025
KING LUTHER CAPITAL MANAGEMENT CORP
13F 13D/G
Company · Luther King Capital Management Corporation
4%
from 13D/G
3,541,170
$13,491,858 30 Jun 2025
ORBIMED ADVISORS LLC
13F 3/4/5
Company · 10%+ Owner
11%
6,059,528
$23,086,802 30 Jun 2025
Rubric Capital Management LP
13F
Company
8.6%
4,601,977
$17,533,532 30 Jun 2025
13F
AIGH Capital Management LLC
13F
Company
7.2%
3,867,523
$14,735,262 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
4.1%
2,211,316
$8,425,114 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
4%
2,147,886
$8,183,446 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
3.4%
1,835,649
$6,993,823 30 Jun 2025
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
2.8%
1,472,527
$5,610,328 30 Jun 2025
13F
5AM Venture Management, LLC
13F
Company
2.2%
1,200,647
$4,574,465 30 Jun 2025
13F
Nantahala Capital Management, LLC
13F
Company
1.9%
995,438
$3,792,619 30 Jun 2025
13F
Velan Capital Investment Management LP
13F
Company
1.7%
917,668
$3,496,315 30 Jun 2025
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
1.6%
856,994
$3,266,000 30 Jun 2025
13F
UBS Group AG
13F
Company
1.6%
855,302
$3,258,700 30 Jun 2025
13F
STATE STREET CORP
13F
Company
1.5%
805,009
$3,067,084 30 Jun 2025
13F
APIS CAPITAL ADVISORS, LLC
13F
Company
1.4%
752,000
$2,865,120 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.4%
749,484
$2,855,760 30 Jun 2025
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
1.2%
659,711
$2,513,499 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1%
538,470
$2,051,571 30 Jun 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.94%
503,705
$1,919,000 30 Jun 2025
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.94%
500,000
$1,905,000 30 Jun 2025
13F
Tejara Capital Ltd
13F
Company
0.93%
497,730
$1,896,351 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.53%
283,138
$1,078,756 30 Jun 2025
13F
DIADEMA PARTNERS LP
13F
Company
0.41%
217,623
$829,144 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.26%
138,460
$527,533 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.24%
130,075
$495,586 30 Jun 2025
13F
J. Goldman & Co LP
13F
Company
0.23%
121,500
$462,915 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.19%
101,888
$388,193 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.18%
94,809
$361,222 30 Jun 2025
13F
Balanced Rock Investment Advisors LLC
13F
Company
0.17%
90,968
$346,588 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.15%
81,458
$310,356 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.14%
76,151
$290,135 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.14%
74,477
$283,758 30 Jun 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
67,900
$258,699 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.12%
66,199
$252,219 30 Jun 2025
13F
NOMURA HOLDINGS INC
13F
Company
0.12%
66,072
$251,734 30 Jun 2025
13F
Pale Fire Capital SE
13F
Company
0.11%
57,128
$217,658 30 Jun 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
54,500
$207,636 30 Jun 2025
13F
Persistent Asset Partners Ltd
13F
Company
0.09%
50,107
$190,908 30 Jun 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.08%
45,071
$172,000 30 Jun 2025
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0.08%
43,746
$166,672 30 Jun 2025
13F
HRT FINANCIAL LP
13F
Company
0.08%
40,667
$154,000 30 Jun 2025
13F
COMERICA BANK
13F
Company
0.07%
38,662
$147,302 30 Jun 2025
13F
Thomasville National Bank
13F
Company
0.07%
37,500
$142,875 30 Jun 2025
13F
WEALTHEDGE INVESTMENT ADVISORS, LLC
13F
Company
0.07%
36,569
$139,328 30 Jun 2025
13F
XTX Topco Ltd
13F
Company
0.06%
31,756
$120,990 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
31,721
$120,858 30 Jun 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.05%
29,217
$111,000 30 Jun 2025
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.05%
28,670
$109,233 30 Jun 2025
13F
Lido Advisors, LLC
13F
Company
0.05%
27,500
$104,775 30 Jun 2025
13F

Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q3 2025

As of 30 Sep 2025, scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,958,051 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Rubric Capital Management LP, Weiss Asset Management LP, BlackRock, Inc., VANGUARD GROUP INC, TUDOR INVESTMENT CORP ET AL, KING LUTHER CAPITAL MANAGEMENT CORP, HSBC HOLDINGS PLC, MORGAN STANLEY, and GLAZER CAPITAL, LLC. This page lists 109 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
95
Q3 2025 holders
108
Holder diff
13
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .